Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new ...
Dexcom said Monday it has made Jereme Sylvain chief operating officer, expanding the executive’s role at the diabetes ...
The CMS is expanding the number of covered conditions under the program to include heart failure, COPD, substance use disorders and tobacco cessation.
Gaining authorization for transvaginal gynecologic procedures expands the list of indications for da Vinci SP in Europe.
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
The agency says the CMS and MA organizations aren’t doing enough to screen durable medical equipment providers, especially ...
The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha ...
Most medical device manufacturers start their consultation with me asking one of two questions: “Do we need a human factors ...
CEO Robert Ford has said the atrial fibrillation treatment, along with the company's Volt PFA device, is expected to help ...
The decision is part of J&J’s strategy to prioritize resources for the greatest impact and positions Laminar for success ...
Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and ...
Companies including Tempus AI and Updoc are tasked with building an agentic AI system for managing heart failure.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results